[JANX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 14.96%
YoY- -30.45%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,057 2,048 2,845 1,813 2,365 1,589 1,616 -24.70%
PBT -17,508 -17,459 -16,065 -16,696 -16,888 -13,410 -13,416 19.47%
Tax 349 -453 -4,805 -2,652 -373 -264 -74 -
NP -17,508 -17,459 -11,260 -14,044 -16,515 -13,146 -13,416 19.47%
Tax Rate - - - - - - - -
Total Cost 18,565 19,507 14,105 15,857 18,880 14,735 15,032 15.15%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,656.39 -852.49 -395.78 -774.63 -698.31 -827.31 -830.20 58.68%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.42 -0.42 -0.27 -0.34 -0.40 -0.32 -0.33 17.49%
EPS Diluted -0.42 -0.42 -0.27 -0.34 -0.40 -0.32 -0.33 17.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.